#orphandrugdesignation — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #orphandrugdesignation, aggregated by home.social.
-
Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults
Crinetics Pharmaceuticals, Inc. PALSONIFY is the first once-daily, oral therapy approved to treat acromegaly in the European Union…
#Europe #EU #EuropeanCommission #acromegaly #adultpatients #CrineticsPharmaceuticals #europeaneconomicarea #EuropeanUnion #Inc. #OrphanDrugDesignation #Palsonify #somatostatinreceptortype
https://www.europesays.com/europe/24531/ -
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company KER-0193,…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Genetics #autismspectrumdisorder #Bioscience #development #FragileXsyndrome #geneticcause #OrphanDrugDesignation #PediatricDrug #Science #Servier
https://www.newsbeep.com/us/141283/ -
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company KER-0193,…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Genetics #autismspectrumdisorder #Bioscience #development #FragileXsyndrome #geneticcause #OrphanDrugDesignation #PediatricDrug #Science #Servier
https://www.newsbeep.com/us/141283/